Wuhan Hiteck Biological Pharma Co Ltd (300683) - Total Liabilities

Latest as of September 2025: CN¥393.09 Million CNY ≈ $57.52 Million USD

Based on the latest financial reports, Wuhan Hiteck Biological Pharma Co Ltd (300683) has total liabilities worth CN¥393.09 Million CNY (≈ $57.52 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Wuhan Hiteck Biological Pharma Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Wuhan Hiteck Biological Pharma Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Wuhan Hiteck Biological Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Wuhan Hiteck Biological Pharma Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Wuhan Hiteck Biological Pharma Co Ltd Competitors by Total Liabilities

The table below lists competitors of Wuhan Hiteck Biological Pharma Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
China Haisum Engineering Co Ltd SHE:002116	China	CN¥3.11 Billion
Qinghai Huzhu Barley Wine Co Ltd SHE:002646	China	CN¥326.00 Million
SNT Dynamics Co Ltd KO:003570	Korea	₩360.96 Billion
Prime Energy PE Ltd TA:PRIM	Israel	ILA1.35 Billion
Network18 Media & Investments Limited NSE:NETWORK18	India	Rs40.09 Billion
Lumibird SA PA:LBIRD	France	€222.60 Million
Qingdao Huijintong Power SHG:603577	China	CN¥4.23 Billion
Summit Hotel Properties Inc NYSE:INN	USA	$1.55 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Wuhan Hiteck Biological Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Wuhan Hiteck Biological Pharma Co Ltd (300683) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wuhan Hiteck Biological Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wuhan Hiteck Biological Pharma Co Ltd (2013–2024)

The table below shows the annual total liabilities of Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥525.05 Million ≈ $76.83 Million	+10.37%
2023-12-31	CN¥475.73 Million ≈ $69.61 Million	+28.16%
2022-12-31	CN¥371.20 Million ≈ $54.32 Million	+4.72%
2021-12-31	CN¥354.46 Million ≈ $51.87 Million	-23.21%
2020-12-31	CN¥461.62 Million ≈ $67.55 Million	+12.86%
2019-12-31	CN¥409.03 Million ≈ $59.85 Million	-8.24%
2018-12-31	CN¥445.77 Million ≈ $65.23 Million	+67.82%
2017-12-31	CN¥265.62 Million ≈ $38.87 Million	-20.91%
2016-12-31	CN¥335.87 Million ≈ $49.15 Million	+21.81%
2015-12-31	CN¥275.74 Million ≈ $40.35 Million	+4.14%
2014-12-31	CN¥264.78 Million ≈ $38.75 Million	+42.03%
2013-12-31	CN¥186.42 Million ≈ $27.28 Million	--

About Wuhan Hiteck Biological Pharma Co Ltd

SHE:300683 China Drug Manufacturers - Specialty & Generic

Market Cap

$489.96 Million

CN¥3.35 Billion CNY

Market Cap Rank

#12181 Global

#3493 in China

Share Price

CN¥25.58

Change (1 day)

-0.74%

52-Week Range

CN¥23.33 - CN¥59.41

All Time High

CN¥84.19